🇺🇸 FDA
Pipeline program

Qingre Huashi Granules combined the modified dual therapy

ShouFa-2022-2-40711

Unknown small_molecule active

Quick answer

Qingre Huashi Granules combined the modified dual therapy for Helicobacter Pylori Infection is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Helicobacter Pylori Infection
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials